<DOC>
	<DOCNO>NCT00434824</DOCNO>
	<brief_summary>In study evaluate effect three different dos oral testosterone undecanoate age men present combination symptom suggestive hypogonadism low blood level male hormone testosterone . Specifically , studied effect : - symptom suggestive low testosterone level - blood testosterone hormone level - bone mass - muscle mass fat mass - muscle strength - prostate - lipid , hematocrit</brief_summary>
	<brief_title>Effects Andriol Testocaps Symptomatic Late-Onset Hypogonadism ( 43203 )</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Subjects least 50 year age A body mass index ( BMI ) 18 34 kg/m^2 Symptoms androgen deficiency ( indicated positive Androgen Deficiency Aging Males ( ADAM ) questionnaire ) Calculated free testosterone measurement &lt; 0.26 nmol/L morning History current diagnosis breast prostate cancer clinically significant abnormal find physical examination include prostate Clinical symptom obstructive benign prostate hyperplasia ( International Prostate Symptom Score ( IPSS ) &gt; 14 ) Prostate specific antigen ( PSA ) level &gt; 4 ng/mL screening Cause androgen deficiency age , e.g . 'classical ' diagnosis primary secondary hypogonadism Hyperprolactinaemia treatment prolactinlowering drug History know chronic polycythemia and/or hematocrit &gt; 50 % screen History presence severe sleep apnea Unstable untreated endocrine disorder History presence clinically significant depression psychiatric disorder clinically relevant cardiovascular , cerebrovascular , endocrine , hepatic , renal hematological disease , thromboembolism/thrombosis etc . , opinion investigator , might compromise subject 's participation trial Use medication would interfere efficacy safety objectives trial</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>